REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Mb Pharma S.R.O. (Czech Republic)

Main Activities: Medicinal and Botanical Manufacturing | Pharmaceutical Preparation Manufacturing
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Other Commercial and Industrial Machinery and Equipment Rental and Leasing | Engineering Services | Custom Computer Programming Services | Research and Development in Nanotechnology
Full name: Mb Pharma S.R.O. Profile Updated: October 15, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Mb Pharma S.R.O. is a company in Czech Republic, with a head office in Prague. The company operates in the Medicinal and Botanical Manufacturing industry. It was first established on August 12, 1998. 25 - 49 (2024) employees currently work for Mb Pharma S.R.O.. The company’s latest financial report indicates a net sales revenue increase of 13% in 2024. Its’ total assets recorded a growth of 2.01%. The net profit margin of Mb Pharma S.R.O. increased by 2.05% in 2024.

Headquarters
Rubesova 72/9
Prague; The City of Prague; Postal Code: 12000

Contact Details: Purchase the Mb Pharma S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Mb Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Mb Pharma S.R.O. report to view the information.
Financial Auditors:
Purchase the Mb Pharma S.R.O. report to view the information.
Incorporation Date:
August 12, 1998
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Mb Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
13%▲
Total operating revenue
11.05%▲
Operating profit (EBIT)
68.14%▲
EBITDA
216.85%▲
Net Profit (Loss) for the Period
3790.91%▲
Total assets
2.01%▲
Total equity
2.4%▲
Operating Profit Margin (ROS)
1.16%▲
Net Profit Margin
2.05%▲
Return on Equity (ROE)
2.28%▲
Debt to Equity Ratio
10.4%▲
Quick Ratio
-0.33%▼
Cash Ratio
-0.15%▼

Similar companies

Synthon, S.R.O.
 
Vuab Pharma A.S.
Cayman Pharma S.R.O.
 
Immunotech S.R.O.
Agel Transfuzni Sluzba A.S.
 
Fagofarma S.R.O.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo